Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats

Frontiers in Pharmacology
2021.0

Abstract

Berberine, a well-known alkaloid, has been proved to possess various pharmacological activities. Previous studies demonstrated that berberine could be extensively metabolized and the metabolites also contributed to its therapeutic effects. However, as for berberine's metabolites, especially phase II metabolites, pharmacokinetics and excretion studies were rarely reported. The objective of this study was to thoroughly investigate the pharmacokinetic and excretion profiles of berberine and its nine metabolites, namely, berberrubine (M1), demethyleneberberine (M2), jatrorrhizine (M3), jatrorrhizine-3-O-beta-D-glucuronide (M4), jatrorrhizine-3-O-sulfate (M5), thalfendine-10-O-beta-D-glucuronide (M6), berberrubine-9-O-beta-D-glucuronide (M7), demethyleneberberine-2-O-sulfate (M8) and demethyleneberberine-2-O-beta-D-glucuronide (M9) in rats. An accurate and reliable LC-MS/MS method was developed and validated for the determination of berberine and its nine metabolites in rat biosamples. Pharmacokinetic profiles of berberine and its nine metabolites were obtained after a single intravenous administration (4.0 mg/kg) and oral administration (48.2, 120 or 240 mg/kg) of berberine in rats. For excretion study, rats were intragastrically administered a single dose of 48.2 mg/kg berberine. Our results showed that berberine could be metabolized rapidly and all the nine metabolites could be detected in vivo. The absolute bioavailability of berberine was 0.37 +/- 0.11%. As for the AUC(0-48 h) values, phase II metabolites were much higher than those of phase I metabolites, suggesting that phase II metabolites were the major metabolites exist in blood circulation. 18.6% of the berberine was excreted in feces as berberrubine (M1). The total recovery of berberine and its nine metabolites from urine, bile and feces was 41.2%. This is the first systematic study about the pharmacokinetics and excretion of berberine and its nine metabolites, which will be beneficial for both better understanding the clinical effects and further development of berberine.

Knowledge Graph

Similar Paper

Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
Frontiers in Pharmacology 2021.0
Berberine and Its Metabolites: Relationship between Physicochemical Properties and Plasma Levels after Administration to Human Subjects
Journal of Natural Products 2014.0
Metabolic profiling integrated with pharmacokinetics to reveal the material basis of Xiaokeyinshui extract combination in the treatment of type 2 diabetes in rats
Journal of Pharmaceutical and Biomedical Analysis 2023.0
A comparative investigation of the interaction and pharmacokinetics of hemoglobin with berberine and its oxymetabolite
Journal of Pharmaceutical and Biomedical Analysis 2021.0
Synthesis of 9-O-glycosyl-berberine derivatives and bioavailability evaluation
Medicinal Chemistry Research 2012.0
Identification of the Metabolites of Scutebarbatine A in Rat Plasma, Bile, Urine, and feces by Using Ultra-high-performance Liquid Chromatography Coupled with Q Exactive Hybrid Quadrupole-orbitrap High-resolution Mass Spectrometry
Current Drug Metabolism 2022.0
Metabolite Profiling of Meridianin C In Vivo of Rat by UHPLC/Q-TOF MS
Journal of Analytical Methods in Chemistry 2021.0
Studies on synthesis, physicochemical properties, biological activities of two novel berberine-based salts with DL-mandelate and cinnamate anions
Journal of Molecular Structure 2023.0
Synthesis of a Novel 9-O Berberine Derivative and Evaluation of Its Hypoglycemic Effect
Molbank 2023.0
Determination of berberine in human plasma by liquid chromatography–electrospray ionization–mass spectrometry
Journal of Pharmaceutical and Biomedical Analysis 2007.0